Multidrug-resistant tuberculosis in migrants, multi-country cluster – ECDC risk assessment
ECDC has published a third update to assess the risk of transmission within the EU of a multidrug-resistant tuberculosis (MDR TB) strain initially detected by Switzerland in seven asylum seekers from the Horn of Africa. Recommendations are given to help improve the understanding and the public health impact of this cluster for the EU.
New tuberculosis drugs approved by European Medicines Agency
The European Medicines Agency has recommended marketing authorisations for three new drugs used for the treatment of multidrug-resistant tuberculosis.
1st Eastern Partnership Ministerial Conference on Tuberculosis and Multi-Drug Resistance Tuberculosis
High-level meeting to discuss the burden of TB and MDR TB and its elimination as a public health problem in the EU/EEA and Eastern Partnership countries.